$127.44
0.59[0.47%]
At close: Apr 29
$127.44
0[0.00%]
PreMarket: 4:11AM EDT
Novo Nordisk
(NYSE:NVO)Novo Nordisk Stock (NYSE:NVO), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/31/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $39.21B | $41.90B | $40.17B | Get Alert |
| 11/02/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $33.07B | $34.62B | $31.83B | Get Alert |
| 08/10/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $31.29B | $32.84B | $32.04B | Get Alert |
| 05/04/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $30.09B | $31.63B | $31.90B | Get Alert |
| 02/01/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $26.76B | $28.18B | $28.77B | Get Alert |
| 11/02/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $23.66B | $24.23B | $22.97B | Get Alert |
| 08/03/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $22.59B | $23.40B | $23.52B | Get Alert |
| 02/02/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $24.04B | $24.90B | $22.48B | Get Alert |
| 10/29/2021 | NVO | Novo Nordisk | Q3 | 2021 | — | — | — | $5.64B | $5.64B | $5.35B | Get Alert |
| 10/29/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $22.55B | $23.15B | $21.35B | Get Alert |
| 08/04/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $21.80B | $22.42B | $21.47B | Get Alert |
| 02/03/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $21.35B | $22.17B | $21.76B | Get Alert |
| 10/30/2020 | NVO | Novo Nordisk | FY | 2020 | — | — | — | $20.11B | $20.69B | $20.39B | Get Alert |
| 10/08/2020 | NVO | Novo Nordisk | Q3 | 2020 | — | — | — | $4.86B | $4.86B | $4.88B | Get Alert |
| 10/08/2020 | NVO | Novo Nordisk | FY | 2020 | — | — | — | $19.22B | $19.77B | $20.18B | Get Alert |
| 02/05/2020 | NVO | Novo Nordisk | FY | 2020 | — | — | — | $18.85B | $19.40B | $18.74B | Get Alert |
| 11/01/2019 | NVO | Novo Nordisk | FY | 2019 | — | — | — | $17.61B | $17.78B | $18.24B | Get Alert |
FAQ
What is the most recent guidance for Novo Nordisk (NVO)?
There have been no specific sales or earnings guidance reported for Novo Nordisk in recent months.
Browse guidance and forecast on all stocks.